Alector ALEC
NASDAQ ALEC
$2.46 -0.05 (-1.99%)
At close: Sep 4, 2026 · 4:00 PM EDT

Alector (ALEC) EV to CFO (2019 - 2026)

Alector's (ALEC) quarterly EV to CFO came in at 1.51 in Q2 2026, down 144.7% year-over-year from 3.38 in Q2 2025, and down 133.51% quarter-over-quarter from 0.65 in Q1 2026.

Analysis

Alector (ALEC) EV to CFO (2019 - 2026) Analysis & Trends

Alector (ALEC) has reported EV to CFO for 8 consecutive years, with 1.51 the latest figure, recorded in Q2 2026.

  • On a quarterly basis, EV to CFO fell 144.7% year-over-year to 1.51 in Q2 2026; TTM through Jun 2026 was 0.33, a 142.49% decrease from a year earlier, with the FY2025 full-year figure at 0.46, down 53.67% from the prior year.
  • EV to CFO was 1.51 for Q2 2026 at Alector, down from 0.65 in the prior quarter.
  • Over five years, EV to CFO peaked at 4.11 in Q4 2024 and troughed at 2.79 in Q4 2023.
  • A 5-year average of 0.87 and a median of 0.48 in 2023 frame the typical range for EV to CFO.
  • The widest YoY moves for EV to CFO: up 1387.48% in 2025, down 5052.12% in 2025.
  • Over 5 years, EV to CFO stood at 1.07 in 2022, then sank by 161.0% to 2.79 in 2023, then surged by 247.35% to 4.11 in 2024, then tumbled by 51.05% to 2.01 in 2025, then tumbled by 175.02% to 1.51 in 2026.
  • The last three EV to CFO figures came in at 1.51 (Q2 2026), 0.65 (Q1 2026), and 2.01 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn
10 Alector 274.68 Mn 101.88 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.51
Mar 31, 2026 -0.65
Dec 31, 2025 2.01
Sep 30, 2025 -0.83
Jun 30, 2025 3.38
Mar 31, 2025 3.81
Dec 31, 2024 4.11
Sep 30, 2024 0.02
Jun 30, 2024 0.98
Mar 31, 2024 -0.30
Dec 31, 2023 -2.79
Sep 30, 2023 0.94
Jun 30, 2023 2.94
Mar 31, 2023 3.16
Dec 31, 2022 -1.07
Sep 30, 2022 -0.35
Jun 30, 2022 -0.42
Mar 31, 2022 2.22
Dec 31, 2021 -19.44
Sep 30, 2021 2.32